Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Mascitelli

Showing results (81-90 of 286) with videos related to

Pageof 29
Sort By:
European Urology|February 16, 2019
Re: John L. Gore, Jonathan L. Wright. Can We Prevent Bladder Cancer Recurrences? Eur Urol 2019;75:602-3Mark R Goldstein, Luca Mascitelli
International Journal of Cancer|May 8, 2013
Explaining sex difference in cancer risk: might it be related to excess iron?Luca Mascitelli, Mark R Goldstein
Annals of Internal Medicine|December 18, 2018
Herpes ZosterMark R Goldstein, Luca Mascitelli
The Lancet. Diabetes & Endocrinology|December 24, 2017
Questioning the safety and benefits of evolocumabLuca Mascitelli, Mark R Goldstein
Circulation|November 25, 2016
Letter by Mascitelli and Goldstein Regarding Article, "Is Statin Monotherapy the Perfect Polypill?"Luca Mascitelli, Mark R Goldstein
Diabetologia|January 30, 2017
PCSK9 inhibition and the global diabetes epidemicLuca Mascitelli, Mark R Goldstein
The New England Journal of Medicine|September 23, 2016
Blood-Pressure and Cholesterol Lowering in the HOPE-3 TrialLuca Mascitelli, Mark R Goldstein
Recenti Progressi in Medicina|August 10, 2007
[Current status of the iron hypothesis of cardiovascular diseases]Jerome L Sullivan, Luca Mascitelli
Lancet (London, England)|May 17, 2011
Aspirin in the prevention of cancerLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|September 13, 2011
Statins, cholesterol depletion and risk of incident diabetesLuca Mascitelli, Mark R Goldstein
Pageof 29

Showing results (81-90 of 286) with videos related to

Sort By:
Pageof 29
European Urology|February 16, 2019
Re: John L. Gore, Jonathan L. Wright. Can We Prevent Bladder Cancer Recurrences? Eur Urol 2019;75:602-3Mark R Goldstein, Luca Mascitelli
International Journal of Cancer|May 8, 2013
Explaining sex difference in cancer risk: might it be related to excess iron?Luca Mascitelli, Mark R Goldstein
Annals of Internal Medicine|December 18, 2018
Herpes ZosterMark R Goldstein, Luca Mascitelli
The Lancet. Diabetes & Endocrinology|December 24, 2017
Questioning the safety and benefits of evolocumabLuca Mascitelli, Mark R Goldstein
Circulation|November 25, 2016
Letter by Mascitelli and Goldstein Regarding Article, "Is Statin Monotherapy the Perfect Polypill?"Luca Mascitelli, Mark R Goldstein
Diabetologia|January 30, 2017
PCSK9 inhibition and the global diabetes epidemicLuca Mascitelli, Mark R Goldstein
The New England Journal of Medicine|September 23, 2016
Blood-Pressure and Cholesterol Lowering in the HOPE-3 TrialLuca Mascitelli, Mark R Goldstein
Recenti Progressi in Medicina|August 10, 2007
[Current status of the iron hypothesis of cardiovascular diseases]Jerome L Sullivan, Luca Mascitelli
Lancet (London, England)|May 17, 2011
Aspirin in the prevention of cancerLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|September 13, 2011
Statins, cholesterol depletion and risk of incident diabetesLuca Mascitelli, Mark R Goldstein
Pageof 29